1.03.2021, 13:30

SPH Preliminary consolidated annual financial statements of Sopharma AD for 2020

Preliminary consolidated annual financial statements of Sopharma AD for 2020

Data	Tytuł	Kurs	Zmiana
2024-09-20	SPH Notification from Rositsa Doneva in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD	12,65	0,00
2024-09-20	SPH Sales revenues for August 2024	12,65	0,00
2024-09-20	SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD	12,65	0,00
2024-09-19	SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD	12,65	0,00
2024-09-18	SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD	13,00	-2,69
2024-09-17	SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD	13,00	0,00
2024-09-16	SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD	13,00	0,00
2024-09-13	SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD	13,20	-4,17
2024-09-12	SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD	14,40	-8,33
2024-09-11	SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD	14,40	0,00